Medical News

RSS

SpineAlign Medical announces VerteLift as new name for vertebral implant system

SpineAlign Medical Inc. announced today that it has chosen a new trademark name, VerteLift, for its vertebral implant system. Formerly called the SpineAlign System, the name reflects the advantages of the product that the Company will leverage going forward.

30 Mar 2010

MedeAnalytics' white paper focuses on potential reductions of annual updates to the IPPS

MedeAnalytics, a leading provider of healthcare performance management solutions, today released a white paper on one of the HITECH Act's measures designed to motivate hospitals to become meaningful users of electronic health records (EHRs): potential negative adjustments to Medicare's market basket updates to the Inpatient Prospective Payment System (IPPS).

30 Mar 2010

CLC bio signs partnership agreement with Ion Torrent

CLC bio, the world's leading bioinformatics solution provider, today announced a partnership with Ion Torrent, a new sequencing company started by Dr. Jonathan Rothberg, the founder of 454 Life Sciences. The partnership will ensure that data can directly flow off of the Ion Personal Genome Machine sequencer and into CLC bio's solutions, like CLC Genomics Workbench or CLC Genomics Server.

30 Mar 2010

FDA allows GeoVax Labs to commence phase 1 clinical trial for HIV/AIDS therapeutic vaccine

GeoVax Labs, Inc., a biotechnology company that creates, develops, and tests innovative HIV/AIDS vaccines, is now allowed by the FDA to begin a phase 1 clinical trial for GeoVax's therapeutic vaccine, which is intended as a treatment for individuals infected with HIV. The company will begin a non-blinded study in HIV infected individuals who started drug treatment during their first year of infection.

30 Mar 2010

Multi-center clinical trial of MyoSure Hysteroscopic Tissue Removal System initiated

Interlace Medical, Inc., today announced that it has initiated a multi-center clinical trial of the MyoSure Hysteroscopic Tissue Removal System. The purpose of this study is to demonstrate that women experience minimal to no pain or discomfort during a MyoSure procedure, when given a mild oral sedative together with a local anesthetic injected into the cervix.

30 Mar 2010

NovaBay Pharmaceuticals reports net income of $2.7M for 2009 against year-ago loss

NovaBay Pharmaceuticals, Inc., a clinical stage specialty pharmaceutical company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported full-year and fourth quarter financial results for 2009. The company also highlighted recent progress of its proprietary and partnered development programs.

30 Mar 2010

Novo Nordisk BlueSheet launched to provide information on diabetes and chronic disease

Novo Nordisk, a global healthcare company and leader in diabetes care, today announced the launch of the Novo Nordisk BlueSheet, a resource for information on diabetes and chronic disease, highlighting key issues in diabetes prevention, detection, treatment and care.

30 Mar 2010

Ascent Therapeutics is now Anchor Therapeutics

Ascent Therapeutics announced today that it has adopted a new name — Anchor Therapeutics. Anchor Therapeutics reflects the Company's core technology and its commitment to building solid, dependable value for patients, partners and investors via its proprietary platform technology.

30 Mar 2010

CTRC initiates patient enrolment in U.S. Phase 2 clinical trial of REOLYSIN

Oncolytics Biotech Inc. announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with carboplatin and paclitaxel in patients with squamous cell carcinoma of the lungs.

30 Mar 2010

Two Phase I studies of Stedivaze demonstrate safety in patients with asthma and COPD

Clinical Data, Inc., today announced results from two Phase I studies of Stedivaze™ (apadenoson), which demonstrated that Stedivaze was safe and well tolerated in patients with asthma and chronic obstructive pulmonary disease (COPD). Stedivaze is a potent and highly selective agonist of the adenosine A2A receptor subtype in development as a pharmacologic stress agent for myocardial perfusion imaging (MPI).

30 Mar 2010

Savient Pharmaceuticals' resubmission of BLA for KRYSTEXXA accepted for FDA review

Savient Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has acknowledged receipt of and accepted for review the March 15, 2010 resubmission of the Biologics License Application for KRYSTEXXA™ (pegloticase), a treatment for chronic gout in patients refractory to conventional therapy.

30 Mar 2010

Neuroscientists prevent memory loss in fruit flies by blocking activity of PI3 kinase signaling protein

By blocking the cellular signaling activity of a protein, a team of neuroscientists at Cold Spring Harbor Laboratory (CSHL) has prevented memory loss in fruit flies caused by brain plaques similar to those thought to cause Alzheimer's disease in humans. The study also resolves a long-standing controversy about the role of this protein, PI3 kinase, which was previously thought to have a protective function against the disease.

30 Mar 2010

Seniors at Springhill retirement community find a secret to stay young and active

Seniors at Springhill retirement community have found a secret to staying young and active—HealthAbility. Springhill resident Joe Bertoncini, 88, has always been active, with 64 Senior Olympic medals over the past 14 years. He says the HealthAbility program has helped him to build on those healthy results.

30 Mar 2010

The Sports Club's operating revenues for fourth-quarter 2009 decrease by 16.3%

The Sports Club Company, Inc. today announced financial results for the fourth quarter and year ended December 31, 2009.

30 Mar 2010

Genetically manipulating rats to emulate Alzheimer's disease in humans

Prof. Claudio Cuello at McGill University and his collaborators have genetically manipulated rats that can emulate Alzheimer's disease in humans, enabling research that will include the development of new treatments. Alzheimer's is a devastating brain condition leading to a progressive decline of memory and other brain functions. Although research mice have been developed in the past, rats are more intelligent than other rodents and the behavior of these rats is rich and predictable, which means that for the first time researchers will be able to detect and study the evolution of learning and memory deficits.

30 Mar 2010

Campbell Soup honored for commitment to food allergy safety, awareness and education

Campbell Soup Company was recently honored by the Food Allergy and Anaphylaxis Network for its commitment to food allergy safety, awareness and education.

30 Mar 2010

Mood altering effects of Phenytoin

Phenytoin is a well known antiepileptic agent widely used throughout the world. Recent clinical studies in patients with bipolar disorder have suggested that, as for other anticonvulsant drugs commonly used in the treatment of bipolar patients including valproate and carbamazepine, phenytoin may have mood-stabilizing effects in addition to its well-known anticonvulsant properties.

30 Mar 2010

Posting calorie counts on menus and menu boards also needed in Ontario

US President Barack Obama's groundbreaking health care legislation includes a provision requiring restaurants to post calories on menus and menu boards. For the past year, Ontario's doctors have been calling for similar action from the government, chain restaurants and school cafeterias in the province and believe now is the perfect time for this initiative to be implemented.

30 Mar 2010

Investment report on Fonar from InvestorSoup.com

InvestorSoup.com announces an investment report featuring Fonar Corp. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

30 Mar 2010

AMGA praises members for including ACOs in health reform legislation

The American Medical Group Association announced significant accomplishments in its advocacy efforts to reward members for the high level of quality, cost-efficient, coordinated care they bring to their communities with the inclusion of language establishing Accountable Care Organizations in the recently passed health reform legislation.

30 Mar 2010

Medical News

SpineAlign Medical announces VerteLift as new name for vertebral implant system

MedeAnalytics' white paper focuses on potential reductions of annual updates to the IPPS

CLC bio signs partnership agreement with Ion Torrent

FDA allows GeoVax Labs to commence phase 1 clinical trial for HIV/AIDS therapeutic vaccine

Multi-center clinical trial of MyoSure Hysteroscopic Tissue Removal System initiated

NovaBay Pharmaceuticals reports net income of $2.7M for 2009 against year-ago loss

Novo Nordisk BlueSheet launched to provide information on diabetes and chronic disease

Ascent Therapeutics is now Anchor Therapeutics

CTRC initiates patient enrolment in U.S. Phase 2 clinical trial of REOLYSIN

Two Phase I studies of Stedivaze demonstrate safety in patients with asthma and COPD

Savient Pharmaceuticals' resubmission of BLA for KRYSTEXXA accepted for FDA review

Neuroscientists prevent memory loss in fruit flies by blocking activity of PI3 kinase signaling protein

Seniors at Springhill retirement community find a secret to stay young and active

The Sports Club's operating revenues for fourth-quarter 2009 decrease by 16.3%

Genetically manipulating rats to emulate Alzheimer's disease in humans

Campbell Soup honored for commitment to food allergy safety, awareness and education

Mood altering effects of Phenytoin

Posting calorie counts on menus and menu boards also needed in Ontario

Investment report on Fonar from InvestorSoup.com

AMGA praises members for including ACOs in health reform legislation

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News